
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-05-07-2014
- Volume 10
- Issue 5
Novartis Publishes eBook of Meningococcal Disease Survivors
Novartis' eBook features images of meningococcal disease survivors from around the world.
"Through a series of what I believe are inspirational photographs of meningococcal disease survivors and families impacted by the disease, this project celebrates the survivors' triumphs and honors those who've tragically lost their lives," said Geddes. "Over my 30-year career, there is not one parent I have worked with who doesn't love their children, want to nurture their children and protect their children. Through these images, I hope parents feel empowered to understand the disease's impact and know the options available to them."
The eBook is the culmination of a worldwide project launched in 2013, aiming to raise awareness of meningococcal disease. Geddes meet with the 15 project participants from eight countries (Australia, Canada, Brazil, Germany, Ireland, Spain, UK, and US) to depict their resilience through their portraits. As global project ambassador, Geddes has also worked to promote awareness and encourage meningococcal disease education through meetings with journalists, patient advocacy organizations, and public officials.
Source:
Articles in this issue
over 11 years ago
Using eClinical Systems for Supply-Chain Managementover 11 years ago
FDA and Industry Take Action for a More Secure Drug Supply Chainover 11 years ago
Packaging Becomes Enabler for Biopharmaceuticalsover 11 years ago
Azzur Group and BioSPEQ Announce Mergerover 11 years ago
Eli Lilly Launches Second Education Program for Medical Studentsover 11 years ago
Global Instability Impacts Brazil's Pharma Marketover 11 years ago
US Biopharma Worries About Losing Lead in Innovationover 11 years ago
Outsourcing Remains Strong In Traditional AreasNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




